Health Canada has given its stamp of approval to an antiviral COVID-19 pill.
The treatment from Pfizer is approved for adult patients with mild or moderate COVID-19 who are also at high risk of becoming more seriously ill.
The pill is made up of a combination of drugs that prevents the virus that causes COVID-19 from replicating once it has infected a patient.
It hasn’t been approved for teenagers or patients who are already in the hospital with COVID-19.
***With files from Casey Kenny